Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4201
CALL
Repligen
RGEN
$9.95B
| $736K | ﹤0.01% |
5,200
-14,800
| -74% | -$2.37M |
|
4202
Metropolitan Bank Holding Corp
MCB
$1.14B
| $735K | ﹤0.01% |
21,175
-209,012
| -91% | -$6.29M |
|
4203
Santander
BSBR
$43.5B
| $735K | ﹤0.01% |
115,605
-533,880
| -82% | -$3.12M |
|
4204
Arrow Financial
AROW
$707M
| $735K | ﹤0.01% |
37,595
-4,879
| -11% | -$99.9K |
|
4205
CALL
NET Power Inc Warrants
NPWR.WS
$25.4M
| $735K | ﹤0.01% |
+218,671
| New | +$757K |
|
4206
Gevo
GEVO
$413M
| $734K | ﹤0.01% |
482,746
-2,595,806
| -84% | -$3.36M |
|
|
CFIV
4207
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
| $734K | ﹤0.01% |
+69,799
| New | +$728K |
|
4208
Fortis
FTS
$27.9B
| $733K | ﹤0.01% |
+17,016
| New | +$741K |
|
4209
CALL
Melco Resorts & Entertainment
MLCO
$2.02B
| $733K | ﹤0.01% |
60,000
-160,000
| -73% | -$1.98M |
|
|
KLRS
4210
Kalaris Therapeutics
KLRS
$95.9M
| $730K | ﹤0.01% |
9,336
+6,340
| +212% | +$603K |
|
4211
PUT
Steel Dynamics
STLD
$33.6B
| $730K | ﹤0.01% |
6,700
-6,100
| -48% | -$621K |
|
4212
Alpha and Omega Semiconductor
AOSL
$745M
| $727K | ﹤0.01% |
22,176
-20,897
| -49% | -$562K |
|
4213
CALL
Evolus
EOLS
$587M
| $727K | ﹤0.01% |
+100,000
| New | +$863K |
|
4214
Nordic American Tanker
NAT
$1.43B
| $726K | ﹤0.01% |
197,844
-6,817,634
| -97% | -$24.6M |
|
4215
Cushman & Wakefield Ltd
CWK
$3.31B
| $725K | ﹤0.01% |
88,630
+68,410
| +338% | +$595K |
|
4216
Public Service Enterprise Group
PEG
$36.5B
| $725K | ﹤0.01% |
11,579
-731,048
| -98% | -$45.6M |
|
4217
NRC Health Common Stock
NRC
$483M
| $723K | ﹤0.01% |
16,615
+4,085
| +33% | +$180K |
|
|
TBRG
4218
DELISTED
TruBridge
TBRG
| $722K | ﹤0.01% |
29,227
-211,030
| -88% | -$5.5M |
|
4219
CALL
iQIYI
IQ
$888M
| $721K | ﹤0.01% |
+135,100
| New | +$759K |
|
|
RAIN
4220
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $721K | ﹤0.01% |
601,143
+556,303
| +1,241% | +$2.78M |
|
4221
Amplify Alternative Harvest ETF
MJ
$117M
| $721K | ﹤0.01% |
20,103
+17,298
| +617% | +$666K |
|
4222
Veracyte
VCYT
$3.48B
| $721K | ﹤0.01% |
28,314
-120,399
| -81% | -$2.92M |
|
4223
Equinox Gold
EQX
$15.2B
| $721K | ﹤0.01% |
157,315
-656,893
| -81% | -$3.29M |
|
4224
CALL
Under Armour
UAA
$2.18B
| $721K | ﹤0.01% |
99,800
| – | – |
|
|
SEVN
4225
Seven Hills Realty Trust
SEVN
$172M
| $718K | ﹤0.01% |
69,965
+49,719
| +246% | +$482K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.